Dimitra Stafylaki

Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae

Sofia Maraki, Viktoria Eirini Mavromanolaki, Panagiotis Moraitis et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2021 · 58 citations

Klebsiella Pneumoniae, Antimicrobial Chemotherapy, Bacterial Pathogens +16

Epidemiology and antifungal susceptibility patterns of <i>Candida</i> isolates from Greek women with vulvovaginal candidiasis

Sofia Maraki, Viktoria Eirini Mavromanolaki, Dimitra Stafylaki et al. · Mycoses · 2019 · 53 citations

Antifungal Agent, Vulvar Diseases, Antifungal Susceptibility Patterns +14

Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients

Dimitra Stafylaki, Sofia Maraki, Katerina Vaporidi et al. · Microbiology Spectrum · 2022 · 33 citations · Full text

Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates

Sofia Maraki, Viktoria Eirini Mavromanolaki, Eleni Magkafouraki et al. · Infection · 2021 · 32 citations

Medical Microbiology, Antibiotics, Klebsiella Pneumoniae +9

Surveillance of antimicrobial resistance in recent clinical isolates of Gram-negative anaerobic bacteria in a Greek University Hospital

Sofia Maraki, Viktoria Eirini Mavromanolaki, Dimitra Stafylaki et al. · Anaerobe · 2020 · 30 citations

Greek University Hospital, Gram-negative Bacteriology, Antimicrobial Susceptibility +8